Rocket


News + Filings
Transactions





PROEHL GERALD T

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/09/2022TENAX THERAPEUTICS, INC.TENXGrantStock Option (right to buy)5k$0.62$3.1k 06/09/2022
01/03/2022Dermata Therapeutics, Inc. GrantStock Option (right to buy)57.9k$1.88$108.8k 01/03/2022
01/03/2022Dermata Therapeutics, Inc. GrantStock Option (right to buy)42.1k$2.07$87.1k 01/03/2022
01/03/2022Dermata Therapeutics, Inc. GrantStock Option (right to buy)4.5k$2.07$9.3k 01/03/2022
01/03/2022Dermata Therapeutics, Inc. GrantStock Option (right to buy)197.6k$1.88$371.5k 01/03/2022
11/23/2021Dermata Therapeutics, Inc. PurchaseCommon Stock20k$2.40$48k 11/23/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock17.9k$0.00$0By Allison Taylor Proehl 2020 Irrevocable Trust08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock8.9k$0.00$0By Meghan Proehl Wilder 2020 Irrevocable Trust08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock35.8k$0.00$0By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 202008/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock361.1k$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock112k$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock181.6k$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock1.2M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionCommon Stock85.6k$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. PurchaseCommon Stock142.9k$0.00$0By Proehl Family Trust08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1d Preferred Stock120.5k$0.00$0By Allison Taylor Proehl 2020 Irrevocable Trust08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1d Preferred Stock60.2k$0.00$0By Meghan Proehl Wilder 2020 Irrevocable Trust08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1d Preferred Stock241.3k$0.00$0By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 202008/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1d Preferred Stock2.4M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1a Preferred Stock2.3M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1b Preferred Stock3.7M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1c Preferred Stock25.6M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1 Preferred Stock1.8M$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionSeries 1a Warrants573.8k$0.00$0By Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. ConversionWarrant to Purchase Common Stock28k$20.50$573.7kBy Proehl Investment Ventures LLC08/16/2021
08/17/2021Dermata Therapeutics, Inc. PurchaseWarrant to Purchase Common Stock142.9k$7.00$1000kBy Proehl Family Trust08/16/2021
08/16/2021Dermata Therapeutics, Inc. PurchaseCommon Stock10k$4.96$49.6kBy Proehl Family Trust08/16/2021
06/10/2021TENAX THERAPEUTICS, INC.TENXGrantStock Option (right to buy)5k$2.00$10k 06/10/2021
05/01/2020TENAX THERAPEUTICS, INC.TENXGrantStock Option (right to buy)500$0.66$330 05/01/2020
06/27/2019SOPHIRIS BIO INC.SPHSGrant 20k$0.78$15.6k 06/27/2019
06/27/2018SOPHIRIS BIO INC.SPHSGrant 20k$2.91$58.2k 06/27/2018
05/01/2018TENAX THERAPEUTICS, INC.TENXGrantStock Option (right to buy)500$6.23$3.1k 05/01/2018
01/23/2018Qualigen Therapeutics, Inc.RTTRGrantNon-qualified Stock Option (Right to Buy)30k$0.34$10.2k 01/23/2018
05/30/2017SOPHIRIS BIO INC.SPHSGrant 20k$2.44$48.8k 05/30/2017
11/29/2016Qualigen Therapeutics, Inc.RTTRGrantStock Option (2015 Equity Incentive Plan)7k$2.37$16.6k 11/29/2016
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy